메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity

WUXI, China, Aug. 5, 2025 -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi site has completed GMP release at the end of July, signifying the company's relentless pursuit of excellence in capacity expansion and business growth. In just 18 months, WuXi XDC has rapidly completed the advanced design, construction, equipment qualification, media fill and GMP release of the DP3
- 김갑성 기자
- 2025-08-05 10:13
Smart Jelly for Smart Aging: Chula's High-Protein Pudding Takes Global Stage

BANGKOK, Aug. 5, 2025 -- Chulalongkorn University's "High-Protein Jelly Pudding with Modified Texture for the Elderly with Swallowing Difficulties," developed by Asst. Prof. Dr. Varanya Techasukthavorn and a team from the Faculty of Allied Health Sciences, won a bronze medal in Geneva, along with a special award from Malaysia. Striking with banana and strawberry flavors, the jelly pudding is easy to consume and provides a high protein content of 7-8 grams per cup to strengthen muscles. It's suitable for the elderly, patients, and those who need additional protein. The team is prepar
- 김갑성 기자
- 2025-08-05 10:00
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine

BEIJING, China, Aug. 5, 2025 -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a key hub for Beijing's life sciences sector. Financing Co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund
- 황정호 기자
- 2025-08-05 08:08
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2025 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial of IBI3032, the company's novel oral GLP-1R agonist. IBI3032 is an orally administered small-molecule
- 김갑성 기자
- 2025-08-05 08:00
LA ROCHE-POSAY AND GLOBAL SKIN HEALTH EXPERTS UNITE TO WARN ABOUT LONG TERM CONSEQUENCES OF DANGEROUS 'BURN LINES' SOCIAL MEDIA TREND

PARIS, Aug. 5, 2025 -- A viral TikTok challenge known as "Burn Lines" or "Sunburn Tattoos" is gaining alarming traction among teenagers and young adults worldwide. The trend, which involves placing tape or stencils on the skin to intentionally burn patterned tan lines, has sparked widespread concern among global health experts. France's Minister of Health stated recently: "For a few seconds of buzz on social media, young people are destroying their skin cells for life. We only get one skin." LA ROCHE-POSAY REAFFIRMS ITS LONGSTANDING COMMITME
- 김갑성 기자
- 2025-08-05 05:15
Gates Foundation Announces Catalytic Funding to Spark New Era of Women-Centered Research and Innovation

[ 메디채널 김갑성 기자 ] Investments Through 2030 to Catalyze Innovation in Maternal, Menstrual, Gynecological, and Sexual Health for Women Globally SEATTLE, Aug. 4, 2025 -- The Gates Foundation today announced a $2.5 billion commitment through 2030 to accelerate research and development (R&D) focused exclusively on women's health. It will support the advancement of more than 40 innovations in five critical, chronically underfunded areas—particularly those affecting women in low- and middle-income countries. "For too long, women have suffered from health conditions that are mi
- 김갑성 기자
- 2025-08-04 22:00
Pulsecare Medical Announces NMPA Approval of NxPFA™, the World's First Nanosecond PFA System, Ushering in the PFA 3.0 Era

SHENZHEN, China, Aug. 4, 2025 -- Pulsecare Medical, a pioneer in cardiovascular intervention technologies, announced that its innovative NxPFA™ nanosecond pulsed field ablation (ns-PFA) systemhas received marketing approval from China's National Medical Products Administration (NMPA). As the world's first third-generation ns-PFA system utilizing high-voltage nanosecond pulses for pulmonary vein isolation (PVI) in atrial fibrillation (AF) treatment, this breakthrough marks the dawn of the PFA 3.0 era and represents the innovative capabilities of Pulsecare Medical in cardiovascular multimodal t
- 김갑성 기자
- 2025-08-04 21:30
Minaris Advanced Therapies Opens New State-of-the-Art GMP Facility to Support Global Cell and Gene Therapy Growth

MUNICH, Aug. 4, 2025 -- Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany. The facility, located in Taufkirchen, strengthens Minaris' global manufacturing network and reinforces its position as a trusted partner in advancing cutting-edge therapies from concept to commercialization. Minaris' new facility builds on over 10 years of experience in both the clinical and commercial manufacture of advanced therapies.
- 김갑성 기자
- 2025-08-04 21:00
Vatech Introduces 'Clever One' - A Game-Changing Dental Viewer Solution for the U.S. Market.

FDA-cleared AI dental platform integrates diagnostic support, treatment planning, and patient consultation into one seamless workflow TEANECK, N.J., Aug. 4, 2025 -- Vatech, a global leader in dental imaging innovation, has officially launched 'Vatech® Clever One', its next-generation all-in-one dental platform, in the United States. Following FDA clearance of its AI-based lesion detection feature, the company now offers U.S. dental professionals a unified diagnostic environment designed to streamline every step of the clinical workflow—from image acquisition and simulation
- 황정호 기자
- 2025-08-04 21:00
IMG Announces Ninth Annual 'Leave Your Mark' Grant Opportunity

INDIANAPOLIS, Aug. 4, 2025 -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to be accepting applications for its annual Leave Your Mark Grant. In its ninth year, the Leave Your Mark initiative is designed to invest in causes addressed by mission and social good organizations around the world. Grant applications will be accepted August 1 through September 12, 2025. IMG will be granting funds to five winners — two mission or social good organizations and three individuals participating in a mission, volun
- 황정호 기자
- 2025-08-04 21:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 05일 15시 40분